Short Interest in Innovator Uncapped Accelerated U.S. Equity ETF (BATS:XUSP) Grows By 520.4% - American Market News
Author: ABMN Staff
Description: Read Short Interest in Innovator Uncapped Accelerated U.S. Equity ETF (BATS:XUSP) Grows By 520.4% at American Market News
Keywords: Innovator Uncapped Accelerated U.S. Equity ETF,BATS:XUSP,XUSP,BATS,Stocks,Options,Put,Call
Date: 2026-06-10T01:10:53+0000

Skip to main content

# Short Interest in Innovator Uncapped Accelerated U.S. Equity ETF (BATS:XUSP) Grows By 520.4%

Posted by ABMN Staff on Jun 10th, 2026

Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Stocktwits

Innovator Uncapped Accelerated U.S. Equity ETF (BATS:XUSP – Get Free Report) saw a large growth in short interest during the month of May. As of May 29th, there was short interest totaling 16,893 shares, a growth of 520.4% from the May 14th total of 2,723 shares. Currently, 1.8% of the shares of the company are sold short. Based on an average trading volume of 5,051 shares, the short-interest ratio is currently 3.3 days.

Get Innovator Uncapped Accelerated U.S. Equity ETF alerts:

## Hedge Funds Weigh In On Innovator Uncapped Accelerated U.S. Equity ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XUSP. NewCorp Financial Services Inc. purchased a new position in Innovator Uncapped Accelerated U.S. Equity ETF in the 4th quarter worth $7,133,000. ATX Financial Planning LLC purchased a new position in shares of Innovator Uncapped Accelerated U.S. Equity ETF during the 4th quarter valued at about $4,167,000. Arax Advisory Partners purchased a new position in shares of Innovator Uncapped Accelerated U.S. Equity ETF during the 4th quarter valued at about $1,587,000. Farther Finance Advisors LLC raised its stake in shares of Innovator Uncapped Accelerated U.S. Equity ETF by 8.9% during the 4th quarter. Farther Finance Advisors LLC now owns 272,984 shares of the company’s stock valued at $12,966,000 after buying an additional 22,243 shares during the last quarter. Finally, Jane Street Group LLC purchased a new position in shares of Innovator Uncapped Accelerated U.S. Equity ETF during the 1st quarter valued at about $744,000.

## Innovator Uncapped Accelerated U.S. Equity ETF Price Performance

Shares of XUSP stock opened at $51.53 on Wednesday. The firm has a market capitalization of $47.67 million, a price-to-earnings ratio of 23.39 and a beta of 1.21. The business has a fifty day moving average of $49.99 and a 200 day moving average of $48.23. Innovator Uncapped Accelerated U.S. Equity ETF has a 1 year low of $39.66 and a 1 year high of $54.13.

## About Innovator Uncapped Accelerated U.S. Equity ETF

(Get Free Report)

The Innovator Uncapped Accelerated U.S. Equity ETF (XUSP) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to provide the potential to outperform the price return of the SPDR S&P 500 ETF (SPY), after achieving performance thresholds. The fund uses four, one-year FLEX Options packages with laddered 3-month expiration dates. XUSP was launched on Aug 11, 2022 and is managed by Innovator.

## Read More

- Five stocks we like better than Innovator Uncapped Accelerated U.S. Equity ETF
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer

Receive News & Ratings for Innovator Uncapped Accelerated U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator Uncapped Accelerated U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.

## You might be interested in:

Proximus Shares Down 2.3% – Time to Sell?
Global Beta Smart Income ETF Trading Down 1.7% – What’s Next?
VanEck Gaming ETF Trading Up 0.8% – Still a Buy?
Shaftesbury Capital Shares Up 3.3% – What’s Next?
Agronomics Shares Down 0.8% – Time to Sell?
Cardiol Therapeutics Shares Down 3.5% – Here’s What Happened